Hunter Immunology Overview

  • Founded
  • 2003
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 1

Hunter Immunology General Information

Description

Developer of medicinal drugs intended to treat patient suffering from chronic obstructive pulmonary disease (COPD).

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Acquirer
Probiomics
Primary Office
  • Avalon Parade 61
  • Sydney, New South Wales 2107
  • Australia
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Hunter Immunology Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Hunter Immunology‘s full profile, request access.

Request a free trial

Hunter Immunology Executive Team (1)

Name Title Board Seat Contact Info
David Radford Chief Executive Officer
To view Hunter Immunology’s complete executive team members history, request access »